|Guidelines for the use and interpretation of assays for monitoring autophagy|
DJ Klionsky, K Abdelmohsen, A Abe, MJ Abedin, H Abeliovich, ...
Autophagy 12 (1), 1-222, 2016
|Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain|
DA Butterfield, F Di Domenico, E Barone
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1842 (9 …, 2014
|Aberrant insulin signaling in Alzheimer's disease: current knowledge|
G Bedse, F Di Domenico, G Serviddio, T Cassano
Frontiers in neuroscience 9, 204, 2015
|Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre‐clinical AD, amnestic mild cognitive impairment …|
A Tramutola, JC Triplett, F Di Domenico, DM Niedowicz, MP Murphy, ...
Journal of neurochemistry 133 (5), 739-749, 2015
|mTOR signaling in aging and neurodegeneration: At the crossroad between metabolism dysfunction and impairment of autophagy|
M Perluigi, F Di Domenico, DA Butterfield
Neurobiology of disease 84, 39-49, 2015
|Plant phenolics and human health: biochemistry, nutrition and pharmacology|
John Wiley & Sons, 2009
|Redox proteomics identification of 4‐hydroxynonenal‐modified brain proteins in Alzheimer's disease: role of lipid peroxidation in Alzheimer's disease pathogenesis|
M Perluigi, R Sultana, G Cenini, F Di Domenico, M Memo, WM Pierce, ...
PROTEOMICS–Clinical Applications 3 (6), 682-693, 2009
|Antioxidants in cervical cancer: chemopreventive and chemotherapeutic effects of polyphenols|
F Di Domenico, C Foppoli, R Coccia, M Perluigi
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1822 (5), 737-747, 2012
|Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of alzheimer disease and other selected age-related neurodegenerative disorders|
F Di Domenico, A Tramutola, DA Butterfield
Free Radical Biology and Medicine 111, 253-261, 2017
|Heme oxygenase-1 posttranslational modifications in the brain of subjects with Alzheimer disease and mild cognitive impairment|
E Barone, F Di Domenico, R Sultana, R Coccia, C Mancuso, M Perluigi, ...
Free Radical Biology and Medicine 52 (11-12), 2292-2301, 2012
|Protein levels of heat shock proteins 27, 32, 60, 70, 90 and thioredoxin-1 in amnestic mild cognitive impairment: an investigation on the role of cellular stress response in …|
F Di Domenico, R Sultana, GF Tiu, NN Scheff, M Perluigi, C Cini, ...
Brain research 1333, 72-81, 2010
|Neuropathological role of PI3K/Akt/mTOR axis in Down syndrome brain|
M Perluigi, G Pupo, A Tramutola, C Cini, R Coccia, E Barone, E Head, ...
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1842 (7 …, 2014
|The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliation|
E Barone, F Di Domenico, C Mancuso, DA Butterfield
Neurobiology of disease 62, 144-159, 2014
|Redox proteomics in aging rat brain: involvement of mitochondrial reduced glutathione status and mitochondrial protein oxidation in the aging process|
M Perluigi, F Di Domenico, A Giorgi, ME Schinina, R Coccia, C Cini, ...
Journal of neuroscience research 88 (16), 3498-3507, 2010
|MASS SPECTROMETRY AND REDOX PROTEOMICS: APPLICATIONS IN DISEASE|
DA Butterfield, L Gu, F Di Domenico, RAS Robinson
Mass spectrometry review, 0
|Impairment of proteostasis network in Down syndrome prior to the development of Alzheimer's disease neuropathology: redox proteomics analysis of human brain|
F Di Domenico, R Coccia, A Cocciolo, MP Murphy, G Cenini, E Head, ...
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1832 (8 …, 2013
|Long-term high-dose atorvastatin decreases brain oxidative and nitrosative stress in a preclinical model of Alzheimer disease: a novel mechanism of action|
E Barone, G Cenini, F Di Domenico, S Martin, R Sultana, C Mancuso, ...
Pharmacological Research 63 (3), 172-180, 2011
|Oxidative stress occurs early in Down syndrome pregnancy: a redox proteomics analysis of amniotic fluid|
M Perluigi, F di Domenico, A Fiorini, A Cocciolo, A Giorgi, C Foppoli, ...
PROTEOMICS–Clinical Applications 5 (3‐4), 167-178, 2011
|Statins more than cholesterol lowering agents in Alzheimer disease: their pleiotropic functions as potential therapeutic targets|
E Barone, F Di Domenico, DA Butterfield
Biochemical pharmacology 88 (4), 605-616, 2014
|Quantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer's disease subjects|
F Di Domenico, R Sultana, E Barone, M Perluigi, C Cini, C Mancuso, ...
Journal of proteomics 74 (7), 1091-1103, 2011